Concord Medical Services
5 hedge funds and large institutions have $173K invested in Concord Medical Services in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
0.02% less ownership
Funds ownership: 0.27% → 0.24% (-0.02%)
18% less capital invested
Capital invested by funds: $212K → $173K (-$38.8K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$156 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$14.8K |
| 2 |
Citigroup
New York
|
-$31 |
CCM Hedge Fund Activity: Q4 2022 in Review
5 of the 6,240 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q4 2022, worth a combined $173K — down 18% from $212K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CCM positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $156. The largest seller was Renaissance Technologies, cutting an estimated $14.8K.
- 5 institutional investors held Concord Medical Services (CCM) as of Q4 2022, up from 4 in Q3 2022.
- Funds reported $173K of Concord Medical Services stock for Q4 2022, down 18% quarter-over-quarter.
- 1 fund opened new Concord Medical Services positions in Q4 2022 and 0 closed out, a net change of +1 holder.
- The largest Concord Medical Services buyer in Q4 2022 was Tower Research Capital (TRC), an estimated $156 added.
- The largest Concord Medical Services seller in Q4 2022 was Renaissance Technologies, an estimated $14.8K sold.
Based on aggregated 13F filings for Q4 2022.